Clinical Trial Update: Higher vs. Lower Dose Heparin for PCI [NA]

View source ↗

Summary

A clinical trial is evaluating higher versus lower doses of heparin during percutaneous coronary intervention to determine optimal dosing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Drugs mentioned

• Heparin (unfractionated heparin)

Snippet

Sponsor: Population Health Research Institute | Conditions: Cardiovascular Diseases, Percutaneous Coronary Intervention | NA | Status: RECRUITING